Summary
Scholar Rock Inc
Founded in 2012
Description
We use our unique technology platform and insights to discover new medicines that break through barriers and find optimal solutions for those who need them.
Strengths
- Scholar Rock Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Scholar Rock Inc was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Scholar Rock Inc's annual revenue
$47301000
Based on Kona Equity data
-
Revenue per employee
$326214
-
Variance of revenue growth
12257.45
-
Annual revenue growth since founding
$3941750
-
Revenue growth rate from first known quarter to current
46472.7%
Employee Count
145 employees
-
Employee growth rate from first known quarter to current
86.0%
Executives
Frank Danehy
Research Principal & Associate
f**@scholarrock.comRafael Rossello
Senior Director, Head Of Pharmacovigilance
r**@scholarrock.comAtsuko Polzin
Vice President, Intellectual Property
a**@scholarrock.comKathy Tran
Senior Accountant
k**@scholarrock.comCaryn Parlavecchio
Chief Human Resources Officer
c**@scholarrock.comMuni Ba
Account Executive
m**@scholarrock.comJay Backstrom
CEO
j**@scholarrock.comMatt Larson
Senior Director, Talent Management
m**@scholarrock.comMelissa Hollfelder
Senior Associate Scientist 1
m**@scholarrock.comGuochen Song
Head of Biometrics
g**@scholarrock.comGeorge Nomikos
Senior Vice President of Clinical Sciences, Head of Muscle Therapeutic Area
g**@scholarrock.comTed Myles
Chief Financial Officer Head of Business Operations
t**@scholarrock.comClare Wilkins
Senior Administrative Assistant
c**@scholarrock.comChristopher Chapron
Senior Scientist
c**@scholarrock.comLan Liu
Associate Director of Biostatistics
l**@scholarrock.comNagesh Mahanthappa
Chief Executive Officer
n**@scholarrock.comGregory Carven
Chief Scientific Officer
g**@scholarrock.comMo Qatanani
Senior Vice President, Head of Biology
m**@scholarrock.comHayley Parker
Vice President, Regulatory Affairs
h**@scholarrock.comKerry Costello
Senior Director, Market Development
k**@scholarrock.comLisa Matovcik
Vice President and Senior IP Counsel
l**@scholarrock.comJoseph Kalt
Planning Senior Director, Product
j**@scholarrock.comPaul Miller
Senior Manager, Clinical Trial
p**@scholarrock.comRyan Iarrobino
Senior VP, Clinical Development & Operations
r**@scholarrock.comLu Gan
Head Vice President, Medical Research
l**@scholarrock.comDeborah Meshulam
Vice President, Operations
d**@scholarrock.comSam Wakefield
Vice President, Corporate Law
s**@scholarrock.comChristine Jong
Operations Senior Manager, Human Resources
c**@scholarrock.comErin Moore
Senior VP, Finance
e**@scholarrock.comPhone Rock
Chief Executive Officer
p**@scholarrock.comSal Falzone
Controller
s**@scholarrock.comJunlin Ho
General Counsel & Corporate Secretary
j**@scholarrock.comKatherine Turner
Senior VP, Research, Partnership
k**@scholarrock.comChristopher Fuller
IT Director, Research & Development
c**@scholarrock.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
796 K
-
Page views per visitor
2.0
-
Daily time
3:00
-
Bounce Rate
63.0 %
Location
Unlock unlimited leads
Similar Companies
Pliant Therapeutics Inc
pliantrx.com- Founded in 2015
- Location: South San Francisco, CA
- Annual Revenue: $6.6M
- Employees: 101
- Pliant is a biotechnology company focused on developing breakthrough treatments for fibrotic diseases. They are dedicated to bringing hope to patients with fibrosis through the discovery and development of novel therapies. Pliant's approach involves ta...
Aura Biosciences
aurabiosciences.com- Founded in 2007
- Location: Cambridge, MA
- Annual Revenue: $17.6M
- Employees: 52
- Aura Biosciences is pioneering a first in class technology to treat a wide variety of solid tumor types. We are initially pursuing cancers where patients are in need of a transformational change in treatment options, such as choroidal melanoma, so they...
GlycoMimetics
glycomimetics.com- Founded in 2003
- Location: Rockville, MD
- Annual Revenue: $104.0K
- Employees: 52
- GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...
Harpoon Therapeutics
harpoontx.com- Founded in 2015
- Location: South San Francisco, CA
- Annual Revenue: $20.6M
- Employees: 104
- Harpoon Therapeutics is an immuno oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases. Harpoon has created a novel antibody-based d...
Vedanta Biosciences Inc
vedantabio.com- Location: Cambridge, MA
- Annual Revenue: $33.8M
- Employees: 100
- Vedanta Biosciences is a biotechnology company that pioneers the rational design of drugs made of defined consortia of bacteria found in the gut ecosystem. They have discovered commensal gut bacteria involved in immune regulation and immune potentiatio...
Jounce Therapeutics
jouncetx.com- Founded in 2013
- Location: Cambridge, MA
- Annual Revenue: $82.0M
- Employees: 61
- Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in developing therapies that enable the immune system to attack tumors. Through the use of its Translational Science Platform, the Company first focuses on spec...
Key Information
- Name: Scholar Rock Inc
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge Biotechnology in Cambridge Small Biotechnology in Cambridge Mid-size Biotechnology in Cambridge
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2012 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Organizations General #Education General #Education #Organizations
Frequently Asked Questions
Scholar Rock Inc's headquarters are located at 620 MEMORIAL Dr., 2ND Fl. Cambridge, MA 02139.
Scholar Rock Inc's official website is scholarrock.com
Scholar Rock Inc's annual revenue is $47.3 M.
Scholar Rock Inc's SIC: 87; 873
Scholar Rock Inc's NAICS: 5417; 541.
Scholar Rock Inc has 145 employees
Scholar Rock Inc is in the industry of Biotechnology.
